Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 3:26 PM
Ignite Modification Date:
2025-12-25 @ 1:43 PM
NCT ID:
NCT02702492
Pre Assignment Details:
A total of 60 participants were enrolled and randomized to receive treatment in 2 phases, Dose Escalation (Part A \[23 participants\] and Part B \[27 participants\]; and Dose Expansion Phases (Part C \[10 participants\]). Study was terminated prematurely due to a lack of efficacy during primary analysis and therefore, efficacy, pharmacokinetic (PK) and pharmacodynamics (PDn) assessments were not determined.
Recruitment Details:
This study was conducted at 8 investigative sites in the United States and Canada from 08 Jun 2016 to 26 Jan 2021.
Study:
NCT02702492
Study Brief:
Results Section:
NCT02702492